Medical startup Anges Inc. said Thursday it will soon start Japan's first clinical test on humans of a potential vaccine for the new coronavirus, after gaining formal approval from an Osaka City University Hospital committee.Anges said it will start recruiting participants for the clinical test to be held at the university hospital, aiming to earn the government's authorization to manufacture and sell the DNA vaccine by the spring to fall of next year.In mid-June, Osaka Gov. Hirofumi Yoshimura announced the clinical test would begin next Tuesday, initially targeting 20 to 30 medical workers…READ FULL ARTICLE